News Shire tipped as next big pharma takeover target After trial failure, shares rallied on takeover rumours
News Shire's Hunter Syndrome cognitive impairment drug fails Trial missed primary and secondary endpoints
News Shire CEO backs outcomes-based deals in rare diseases Strategy could help make rare disease drugs affordable
News Judge throws out Allergan patents, criticises Native America... Federal court throws out patents on Restasis
News Intercept shares dive after FDA safety alert on liver drug Regulator warns of death risk in patients on higher than recommended dose.
Partner Content Partner Content 5 Key Reasons Why You Should Attend Europe's Leading Ophthal... 5 Key Reasons Why You Should Attend
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
